-
-
-
-
-
-
-
SOLIGENIX receives positive EMA opinion for SGX945 orphan drug designation
-
-
-
-
-
-
-
Soligenix, Inc. (SNGX) Misses Q3 EPS by 58c
-
-
-
-
-
-
-
Soligenix, Inc. (SNGX) Misses Q4 EPS by 106c
-
-
-
-
-
-
-
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
-
-
-
-
-
-
-
Soligenix (SNGX) Receives European Patent for Improved Production of Synthetic Hypericin
-
-
-
416,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

